From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion. Details follow below.
Blackstone announces final close of $6.3B Life Sciences...
From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....
Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round.
Premier Partners led the investment, with KB Investment,...
China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...
Vdyne announced that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system.
Maple Grove, Minnesota-based Vdyne develops a...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....
Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round.
Premier Partners led the investment, with KB Investment,...
China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...
Vdyne announced that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system.
Maple Grove, Minnesota-based Vdyne develops a...